Therefore, the above results suggest that there may be a relevant role for the upregulation of eNOS expression in the early stages of CRC, where the Lgr5-positive stem cell population is in expansion, and also that the upregulation of this NOS isoform is maintained in more advanced and invasive genotypes. The gene discussed is NOS3; the disease is colorectal carcinoma.